STOCKHOLM, Feb. 13, 2023 /PRNewswire/ -- IRRAS, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback